CagriSema (CS5)

Description

Overview

CagriSema is a dual-peptide formulation combining Cagrilintide and Semaglutide in equal proportions. It is developed for laboratory research focusing on metabolic pathways, peptide synergy, and regulatory biological systems.

Key Features

• Dual-compound peptide formulation
• High purity lyophilized blend
• Designed for synergy-based research
• Consistent and stable composition

Research Applications

• Metabolic pathway studies
• Multi-peptide interaction research
• Hormonal regulation analysis
• Advanced laboratory experimentation

Product Specifications

• Form: Lyophilized powder
• Compound: Cagrilintide + Semaglutide
• Blend Ratio: 2.5mg / 2.5mg
• Purity: ≥98% (each component, typical)
• Storage: Store at -20°C

Reconstitution

Reconstitute with bacteriostatic water under sterile laboratory conditions. Ensure proper handling and measurement for research accuracy.

Disclaimer

This product is strictly intended for research purposes only. Not for human consumption, medical use, or therapeutic applications.